on OXURION (EBR:OXUR)
Oxurion receives transparency notifications from UBS Group AG
Leuven, Belgium - August 7, 2025 - Oxurion NV, a Leuven-based biopharmaceutical company listed on Euronext Brussels, has received transparency notifications from UBS Group AG. On July 24, 2025, UBS held 803,499 shares, exceeding the 3% threshold, thanks to the purchase of voting paper. The following day, July 25, 2025, UBS no longer held any shares, having sold its holdings, bringing its threshold below 3%.
Oxurion emphasizes the importance of Belgian transparency regulations in informing the market and maintaining investor confidence. These share movements signal market activity and investor interest in the company.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news